Latest News

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Despite a few bumps in the road, Canadian markets have shown resilience, closing October near record highs even amid cautious signals from central banks and evolving trade dynamics. In this context, penny stocks—though an older term—remain relevant for investors seeking opportunities in smaller or newer companies that offer a mix of affordability and growth potential. By focusing on those with strong financials, these stocks can provide intriguing possibilities for those looking to explore...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...

Key Insights Vector's estimated fair value is NZ$6.57 based on 2 Stage Free Cash Flow to Equity Current share price of...

Some stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss. Spare a thought for...

In the current U.S. market landscape, major stock indexes have experienced a pullback, with tech shares leading the decline despite some companies posting strong quarterly results. Amidst this backdrop of fluctuating indices and economic uncertainty, identifying growth companies with high insider ownership can be crucial for investors seeking potential resilience and alignment of interests between management and shareholders.

Rani Therapeutics Holdings announced it would present preclinical data on its RaniPill® oral delivery platform at ObesityWeek® 2025, highlighting that oral semaglutide (RT-116) in dogs is bioequivalent to subcutaneous injections and produces similar weight loss. This research could generate interest, as it demonstrates the potential for the RaniPill to enable oral delivery of peptide drugs traditionally administered via injection. We'll examine how these promising preclinical results for...

Pacific Biosciences of California (PACB) shares jumped after news broke that ARK Investment Management, led by Cathie Wood, had acquired over one million shares. This high-profile buy is increasing investor attention and speculation around PacBio’s DNA sequencing technology and its growth outlook. See our latest analysis for Pacific Biosciences of California. ARK’s sizeable buy-in comes as PacBio’s share price has staged a sharp reversal. After months of drifting, the past 30 days saw a...

Méliuz S.A. ( BVMF:CASH3 ), is not the largest company out there, but it saw a decent share price growth of 11% on the...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

We feel now is a pretty good time to analyse Blend Labs, Inc.'s ( NYSE:BLND ) business as it appears the company may be...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

To the annoyance of some shareholders, Coveo Solutions Inc. ( TSE:CVO ) shares are down a considerable 27% in the last...

Stepan Company's ( NYSE:SCL ) periodic dividend will be increasing on the 15th of December to $0.395, with investors...

Key Insights The projected fair value for Dr. Martens is UK£1.13 based on 2 Stage Free Cash Flow to Equity Dr. Martens...

Corporativo Fragua, S.A.B. de C.V.'s ( BMV:FRAGUAB ) robust recent earnings didn't do much to move the stock. However...

The subdued stock price reaction suggests that Industrias Peñoles, S.A.B. de C.V.'s ( BMV:PE&OLES ) strong earnings...

Key Insights The projected fair value for GMéxico Transportes. de is Mex$32.90 based on 2 Stage Free Cash Flow to...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Key Insights Bupa Arabia for Cooperative Insurance's significant private companies ownership suggests that the key...

The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can do...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...

NetLink NBN Trust (SGX:CJLU) reported that earnings are forecast to grow at 7.1% per year, while revenue is projected to rise by 1.8% per year, which is slower than the wider Singapore market’s expected 3.8% growth. Net profit margins slipped to 21.9% from 23.8% the previous year, and recent earnings momentum has softened, with average earnings growth of 2.1% annually over the last five years but a decline in the most recent period. Investors are now weighing a slightly above-market earnings...

As the U.S. market navigates a mixed landscape with the Dow faltering and Nasdaq gaining momentum, investors are keenly observing how tech giants' cloud computing deals and AI investments are influencing broader market sentiment. In this context, identifying high-growth tech stocks often involves looking for companies that are effectively capitalizing on emerging technologies and strategic partnerships to drive innovation and revenue growth.